Promising early results from largest-ever trial testing LSD for anxiety | New Atlas

Biopharmaceutical company MindMed has announced the first topline data from a novel Phase 2 trial testing high doses of LSD as a treatment for anxiety. The results indicate one to two LSD sessions can generate rapid and sustained reductions to anxiety, however, significantly larger trials will be needed to validate these findings.

#science #medicine #health #research #psychiatry #psychotherapy #drugs #LSD #anxiety

https://newatlas.com/science/lsd-for-anxiety-phase2-trial-mindmed-early-results/